Priority review for Welireg is based on data from the Phase II LITESPARK-015 trial, which showed promising response rates in patients with advanced, unresectable, or metastatic pheochromocytoma and ...

A pheochromocytoma is a type of tumor found in the adrenal ... Most pheochromocytomas are actually discovered incidentally (by accident) during some type of imaging study (MRI, CT Scan) done for an ...

Diagnosing adrenal tumors often requires complex and costly laboratory and imaging procedures ... focused on the evaluation of postoperative management of patients with pheochromocytoma assessing ...

Laparoscopic surgery, also referred to as minimally invasive surgery (MIS) or laparoscopy, is a surgical technique in which a thin, camera-equipped surgical device is inserted into the abdomen or ...

The FDA has accepted a priority review sNDA for Welireg in adults and pediatric patients with advanced or metastatic pheochromocytoma and paraganglioma. The U.S. Food and Drug Administration (FDA) has ...

Zircaix, a PET imaging drug for ccRCC, has been submitted for FDA approval and received Breakthrough designation, potentially allowing priority review. The phase 3 ZIRCON trial showed Zircaix's high ...

The FDA granted priority review for belzutifan for treating advanced pheochromocytoma and paraganglioma, with a PDUFA date set for May 26, 2025. The FDA granted priority review to a supplemental new ...

Jan. 14, 2025 — Using advanced imaging techniques and precise microfluidics control to stretch out curly DNA into a straight line, new research demonstrates techniques for stretching and ...

Two new PET radiotracers have outperformed the only current Food and Drug Administration (FDA) approved radiotracer for detecting tau tangles in the brain, a hallmark of Alzheimer's disease. In a ...